ANI Pharmaceuticals Inc. (ANIP) Business Metric Overview

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

ANI Pharmaceuticals Inc. (ANIP)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

54.22

0.29 (0.54%)

At close: Jan 14, 2025, 3:59 PM

54.16

-0.11%

After-hours Jan 14, 2025, 04:00 PM EST

ANI Pharmaceuticals Inc. Revenue Breakdown

Quarter	Sep 30, 2024	Mar 31, 2020	Sep 30, 2019	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014	Dec 31, 2013	Sep 30, 2013	Jun 30, 2013
Unapproved Products Revenue	5.50M	4.40M	4.70M	6.70M	7.90M	6.70M	6.20M	7.70M	5.00K	100.00K	100.00K	10.50M	100.00K	100.00K	100.00K	100.00K	100.00K	3.80M	100.00K	9.98K	134.75K	105.60K
Unapproved Products Revenue Growth	+25.00%	-6.38%	-29.85%	-15.19%	+17.91%	+8.06%	-19.48%	+153900.00%	-95.00%	0.00%	-99.05%	+10400.00%	0.00%	0.00%	0.00%	0.00%	-97.37%	+3700.00%	+901.80%	-92.59%	+27.60%	n/a

Revenue by Geography

Quarter	Dec 31, 2023
Canada Revenue	565.00K
Canada Revenue Growth	n/a
United States Revenue	486.25M
United States Revenue Growth	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015
Selling, General, and Administrative Revenue	79.08M	52.82M	48.02M	44.46M	42.01M	38.76M	36.47M	33.19M	30.08M	31.96M	28.82M	30.71M	17.18M	18.82M	17.59M	14.37M	15.72M	21.21M	13.68M	14.01M	14.36M	14.19M	13.28M	13.38M	11.77M	9.96M	8.96M	8.88M	8.02M	7.38M	7.29M	7.37M	6.93M	7.63M	5.90M	5.46M	5.40M	5.55M	4.75M
Selling, General, and Administrative Revenue Growth	+49.70%	+10.00%	+8.00%	+5.84%	+8.38%	+6.28%	+9.88%	+10.33%	-5.87%	+10.90%	-6.15%	+78.72%	-8.71%	+7.01%	+22.43%	-8.65%	-25.87%	+55.03%	-2.36%	-2.39%	+1.19%	+6.81%	-0.69%	+13.65%	+18.14%	+11.23%	+0.80%	+10.76%	+8.70%	+1.19%	-1.03%	+6.37%	-9.18%	+29.20%	+8.23%	+1.04%	-2.74%	+16.84%	n/a
Research and Development Revenue	10.13M	7.30M	10.51M	9.87M	11.12M	7.37M	5.92M	5.22M	7.66M	4.17M	5.27M	3.14M	2.46M	2.81M	2.97M	3.68M	2.94M	3.04M	6.34M	4.68M	4.98M	5.77M	4.37M	3.48M	4.67M	5.14M	2.10M	2.65M	2.63M	2.17M	1.62M	135.00K	1.04M	764.00K	966.00K	661.00K	815.00K	995.00K	403.00K
Research and Development Revenue Growth	+38.82%	-30.59%	+6.53%	-11.28%	+50.81%	+24.48%	+13.44%	-31.80%	+83.84%	-21.03%	+67.96%	+27.85%	-12.44%	-5.49%	-19.41%	+25.31%	-3.16%	-52.16%	+35.61%	-6.10%	-13.70%	+32.01%	+25.59%	-25.39%	-9.15%	+144.39%	-20.71%	+0.65%	+21.55%	+33.93%	+1098.52%	-87.03%	+36.26%	-20.91%	+46.14%	-18.90%	-18.09%	+146.90%	n/a